Full-Time

Account Manager

Posted on 12/17/2024

Benchling

Benchling

501-1,000 employees

Cloud-based platform for life sciences R&D

Compensation Overview

$100k - $152kAnnually

+ Commission + Total on-target earnings

Senior, Expert

Boston, MA, USA

This is a hybrid role, which may require some in-office days.

Category
Customer Success Management
Sales & Account Management
Required Skills
Sales
Requirements
  • BS or M.Sc. in Biology, Molecular Biology, Genetics, Biotechnology, Bioengineering or similar Life Science field with 3+ years experience in Life Sciences, ideally in a lab or research setting
  • 5+ years of Account management, Customer Success, Renewal Management, Sales, Professional Services, or Consulting experience in a SaaS software environment with the ability to forge relationships with users, decision makers, and influential stakeholders
  • 3-5+ years commercial experience in negotiations utilizing skills to handle contract discussions and ensure favorable outcomes for both the customer and the company
  • An understanding of Life Sciences R&D processes and scientific concepts. Demonstrated ability to immediately interface and build trust with Scientists, as well as Director & VP Level Business and IT leaders in top Biotech and Pharma companies
  • Excellent communication skills, able to communicate confidently and concisely in verbal, written and presentation formats to all types of audiences
  • Self-motivated, independent, adaptable, and can thrive in a fast-paced startup environment
  • Ability to travel 10-20% based on customer needs
Responsibilities
  • Build and maintain productive relationships with key stakeholders across Scientific and IT functional areas including customer champions and economic buyers
  • Experience managing complex customers with highly technical implementations
  • Define and implement customer engagement models throughout the lifetime customer journey to ensure customer satisfaction, governance, expansion opportunity in order to maximize value.
  • Ensure strong processes and systems are in place so that trends in customer contraction and churn are identified early, communicated with the appropriate audience, and appropriate follow-up action is taken
  • Manage the renewal experience, identify and define client challenges or new scientific business case opportunities aligned with the customers’ objectives and vision with support from the extended Benchling team to client success and avoid contraction/churn.
  • Experience negotiating large renewals and expansions in collaboration with sales to drive accurate forecasting around adoption, expansion and retention.

Benchling provides a platform designed for life sciences research and development, primarily catering to biotech and pharmaceutical companies, academic institutions, and research organizations. Its cloud-based platform includes tools like an electronic lab notebook, molecular biology tools, and sample tracking systems, which help scientists manage experimental data, collaborate with colleagues, and streamline workflows. Users can design experiments, record results, and analyze data in an organized manner. Benchling operates on a subscription-based model, offering different pricing tiers based on organizational size and feature needs, ensuring a steady revenue stream. The company differentiates itself by focusing on the specific needs of life sciences R&D, providing essential tools that enhance research efficiency and effectiveness, with the goal of helping clients accelerate their research and bring innovations to market faster.

Company Size

501-1,000

Company Stage

Series F

Total Funding

$400.7M

Headquarters

San Francisco, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Benchling's acquisition of PipeBio enhances AI-powered antibody discovery capabilities.
  • Partnerships with companies like Sanofi accelerate digital transformation in pharmaceutical R&D.
  • Growing demand for cloud-based solutions boosts Benchling's market potential.

What critics are saying

  • Emerging biotech software platforms could erode Benchling's market share.
  • Rapid AI advancements may require significant investment to maintain competitiveness.
  • Data privacy concerns could undermine trust in Benchling's platform.

What makes Benchling unique

  • Benchling offers a comprehensive cloud-based platform for life sciences R&D.
  • The platform integrates AI and machine learning for advanced research capabilities.
  • Benchling's tools facilitate collaboration and data sharing across global scientific teams.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Four months of fully paid parental leave

401(k) plan

Remote working stipend

Yearly company-wide retreat

Monthly gym and wellness stipend

Commuter benefits

100% premiums covered for health, dental, and vision

Weekly company social events

Flexible PTO and company-wide winter holiday shutdown

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

3%

2 year growth

2%
Benchling
Oct 23rd, 2024
Benchling acquires PipeBio to accelerate AI-powered antibody discovery

We’re excited to announce Benchling’s acquisition of PipeBio, a leader in high-throughput bioinformatics analysis, to drive biologics discovery.

ArcticStartup
Oct 22nd, 2024
Danish startup joins US-based Benchling, aiming to revolutionize antibody discovery

The collaboration is expected to improve the efficiency of the discovery process by combining PipeBio's advanced sequence analysis tools with Benchling's established software ecosystem.

SynBioBeta
Oct 10th, 2024
Novonesis Teams Up with Benchling to Supercharge Biosolutions R&D

In a significant move to streamline its R&D operations, Novonesis, a global leader in biosolutions, has selected Benchling as its digital platform to enhance the discovery, development, and testing processes across its scientific teams.

Cradle Bio
Sep 25th, 2024
We Welcome Sam Partovi as Our Chief Commercial Officer

Under his leadership, Benchling expanded its customer base to over 1,000 companies, including more than 20 of the top 50 global biopharma companies and hundreds of emerging, growth, and enterprise biotechnology firms.

Worldtempus
Sep 1st, 2024
Could This Be the Funkiest Watch at Geneva Watch Days?

With heaps of creativity and now a new collaboration with H. Moser & Cie., Benc is starting to leave his "underdog" status behind.

INACTIVE